Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Novel agents in the treatment of chronic lymphocytic leukemia

By: Nishanth Viswanath, PharmD Candidate c/o 2022 Introduction   Chronic lymphocytic leukemia (CLL)  is a hematological malignancy of mature CD5 positive B-lymphocytes that primarily affects elderly patients.1 With the average age of diagnosis being 71, the incidence of CLL is relatively rare in younger populations, though cases have occurred in those under the age of 50.1…

Continue reading →

A Closer Glance at Mycobacterium Avium Complex (MAC) Infection and Treatment

By: Dana Weinstein, PharmD Candidate c/o 2022              Mycobacterium avium complex (MAC) infection in humans is caused by two main species, Mycobacterium avium and Mycobacterium intracellulare. These species are difficult to differentiate and therefore are collectively referred to as Mycobacterium avium-intracellulare (MAI).1 These acid-fast, atypical nontuberculosis mycobacterium (NTM) are the most common cause of lung disease in the U.S.2 MAC is…

Continue reading →

Metastatic Breast CancER+ Treatment

By: Lyana Sayilar, PharmD Candidate c/o 2020 Approved on April 17, 2020, tucatinib (TukysaTM) is indicated to aid in the treatment of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer and could be a potential add-on therapy.3 Among the different types of breast cancers, an increase of HER2, a transmembrane glycoprotein consisting…

Continue reading →

COVID-19 and the vaccine development process: A closer look

By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain responsible for causing COVID-19, continues to have a profound impact on communities at a local, national and global level. As of August 20, 2020, nearly 5.7 million confirmed cases exist in the United States with a total of…

Continue reading →

Issues of Stigma When Addressing Schizophrenia & Mental Illness

By: William Obilisundar, PharmD Candidate c/o 2023, Binghamton University School of Pharmacy and Pharmaceutical Sciences              One of the most interesting events hosted by the Binghamton University School of Pharmacy during the 2019-2020 academic year was a seminar entitled, “Mental Health Awareness: A Focus on Suicide & Stigma,” presented by Dr. Carolyn M. Tyler, Ph.D.,…

Continue reading →

(Volume 9, Issue 6)
A Closer Glance at Mycobacterium Avium Complex (MAC) Infection and Treatment

COVID-19 and the vaccine development process: A closer look

Issues of Stigma When Addressing Schizophrenia & Mental Illness

Metastatic Breast CancER+ Treatment

Novel agents in the treatment of chronic lymphocytic leukemia

View Full Issue

Do You Want to be a Published Author? Submit your Article(s) Today!


 Tweets by @RhoChiPost
HOME: Home Page

ISSUES: Volume 9 . Volume 8 . Volume 7 . Volume 6 . Volume 5 . Volume 4 . Volume 3 . Volume 2 . Volume 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List

Copyright © 2011-2020 Rho Chi Post